AIMS/HYPOTHESIS: Genetic variants of genes for peptide YY (PYY), neuropeptide Y2 receptor (NPY2R) and pancreatic polypeptide (PPY) were investigated for association with severe obesity. SUBJECTS AND METHODS: The initial screening of the genes for variants was performed by sequencing in a group of severely obese subjects (n=161). Case-control analysis of the common variants was then carried out in 557 severely obese adults, 515 severely obese children and 1,163 non-obese/non-diabetic control subjects. Rare variants were genotyped in 700 obese children and the non-obese/non-diabetic control subjects (n=1,163). RESULTS: Significant association was found for a 5' variant (rs6857715) in the NPY2R gene with both severe adult obesity (p=0.002) and childhood obesity (p=0.02). This significant association was further supported by a pooled allelic analysis of all obese cases (adults and children, n=928) vs the control subjects (n=938) (p=0.0004, odds ratio=1.3, 95% CI 1.1-1.5). Quantitative trait analysis of BMI and WHR was performed and significant association was observed for SNP rs1047214 in NPY2R with an increase in WHR in the severely obese children (co-dominant model p=0.005, recessive model p=0.001). Association was also observed for an intron 3 variant (rs162430) in the PYY gene with childhood obesity (p=0.04). No significant associations were observed for PPY variants. Only one rare variant in the NPY2R gene (C-5641T) was not found in lean individuals and this was found to co-segregate with obesity in one family. CONCLUSIONS/ INTERPRETATION: These results provide evidence of association for NPY2R and PYY gene variants with obesity and none for PPY variants. A rare variant of the NPY2R gene showed evidence of co-segregation with obesity and its contribution to obesity should be investigated further.
AIMS/HYPOTHESIS: Genetic variants of genes for peptide YY (PYY), neuropeptide Y2 receptor (NPY2R) and pancreatic polypeptide (PPY) were investigated for association with severe obesity. SUBJECTS AND METHODS: The initial screening of the genes for variants was performed by sequencing in a group of severely obese subjects (n=161). Case-control analysis of the common variants was then carried out in 557 severely obese adults, 515 severely obesechildren and 1,163 non-obese/non-diabetic control subjects. Rare variants were genotyped in 700 obesechildren and the non-obese/non-diabetic control subjects (n=1,163). RESULTS: Significant association was found for a 5' variant (rs6857715) in the NPY2R gene with both severe adult obesity (p=0.002) and childhood obesity (p=0.02). This significant association was further supported by a pooled allelic analysis of all obese cases (adults and children, n=928) vs the control subjects (n=938) (p=0.0004, odds ratio=1.3, 95% CI 1.1-1.5). Quantitative trait analysis of BMI and WHR was performed and significant association was observed for SNP rs1047214 in NPY2R with an increase in WHR in the severely obesechildren (co-dominant model p=0.005, recessive model p=0.001). Association was also observed for an intron 3 variant (rs162430) in the PYY gene with childhood obesity (p=0.04). No significant associations were observed for PPY variants. Only one rare variant in the NPY2R gene (C-5641T) was not found in lean individuals and this was found to co-segregate with obesity in one family. CONCLUSIONS/ INTERPRETATION: These results provide evidence of association for NPY2R and PYY gene variants with obesity and none for PPY variants. A rare variant of the NPY2R gene showed evidence of co-segregation with obesity and its contribution to obesity should be investigated further.
Authors: L Pérusse; T Rice; Y C Chagnon; J P Després; S Lemieux; S Roy; M Lacaille; M A Ho-Kim; M Chagnon; M A Province; D C Rao; C Bouchard Journal: Diabetes Date: 2001-03 Impact factor: 9.461
Authors: P Naveilhan; H Hassani; J M Canals; A J Ekstrand; A Larefalk; V Chhajlani; E Arenas; K Gedda; L Svensson; P Thoren; P Ernfors Journal: Nat Med Date: 1999-10 Impact factor: 53.440
Authors: Rachel L Batterham; Michael A Cowley; Caroline J Small; Herbert Herzog; Mark A Cohen; Catherine L Dakin; Alison M Wren; Audrey E Brynes; Malcolm J Low; Mohammad A Ghatei; Roger D Cone; Stephen R Bloom Journal: Nature Date: 2002-08-08 Impact factor: 49.962
Authors: Chiao-Chien Connie Hung; Fraser Pirie; Jian'an Luan; Emma Lank; Ayesha Motala; Giles S H Yeo; Julia M Keogh; Nicholas J Wareham; Stephen O'Rahilly; I Sadaf Farooqi Journal: Diabetes Date: 2004-09 Impact factor: 9.461
Authors: Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom Journal: N Engl J Med Date: 2003-09-04 Impact factor: 91.245
Authors: R A Pittner; C X Moore; S P Bhavsar; B R Gedulin; P A Smith; C M Jodka; D G Parkes; J R Paterniti; V P Srivastava; A A Young Journal: Int J Obes Relat Metab Disord Date: 2004-08
Authors: Yechiel Friedlander; Guo Li; Myriam Fornage; O Dale Williams; Cora E Lewis; Pamela Schreiner; Mark J Pletcher; Daniel Enquobahrie; Michelle Williams; David S Siscovick Journal: Ann Hum Genet Date: 2010-07-14 Impact factor: 1.670
Authors: Steven C Hunt; Sandra J Hasstedt; Yuanpei Xin; Brian K Dalley; Brett A Milash; Emanuel Yakobson; Richard E Gress; Lance E Davidson; Ted D Adams Journal: Obesity (Silver Spring) Date: 2011-08-04 Impact factor: 5.002
Authors: Zhiyun Wei; Kuixing Zhang; Gen Wen; Karthika Balasubramanian; Pei-an B Shih; Fangwen Rao; Ryan S Friese; Jose P Miramontes-Gonzalez; Geert W Schmid-Schoenbein; Hyung-Suk Kim; Sushil K Mahata; Daniel T O'Connor Journal: J Hypertens Date: 2013-01 Impact factor: 4.844
Authors: Donna K Arnett; Richard B Devereux; Dabeeru C Rao; Na Li; Weihong Tang; Rachel Kraemer; Steven A Claas; Joanlise M Leon; Ulrich Broeckel Journal: J Hypertens Date: 2009-08 Impact factor: 4.844
Authors: Pei-An Betty Shih; Lei Wang; Stephane Chiron; Gen Wen; Caroline Nievergelt; Manjula Mahata; Srikrishna Khandrika; Fangwen Rao; Maple M Fung; Sushil K Mahata; Bruce A Hamilton; Daniel T O'Connor Journal: J Clin Endocrinol Metab Date: 2009-10-09 Impact factor: 5.958
Authors: Liisa Ailanen; Laura H Vähätalo; Henriikka Salomäki-Myftari; Satu Mäkelä; Wendy Orpana; Suvi T Ruohonen; Eriika Savontaus Journal: Front Pharmacol Date: 2018-04-05 Impact factor: 5.810